Literature DB >> 11495519

The multiple faces of Behçet's disease and its aetiological factors.

M Onder1, M A Gürer.   

Abstract

Behçet's disease (BD) is a chronic, inflammatory multisystemic condition of unknown aetiology. It is clinically characterized by recurrent orogenital ulcerations and skin eruptions; ocular manifestations; arthritis; vasculitis and in some cases neurological and large vessel involvement. Aetiology has not been defined, but genetic, environmental, viral, bacterial and immunological factors have been proposed as causative agents. Treatment includes colchicine, thalidomide, steroids and immunosuppressive agents and it is based on the severity of systemic manifestations, such as central nervous system involvement, arterial aneurysms and thrombosis of the major veins. Mortality is related to major system involvement. In this article the different clinical features, the multiple faces of BD and a list of currently suspected aetiological factors of the disease are discussed, and treatment modalities summarized.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495519     DOI: 10.1046/j.1468-3083.2001.00251.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  21 in total

Review 1.  Cardiovascular involvement in Behçet's disease.

Authors:  Yusuf Sezen; Hakan Buyukhatipoglu; Hakan Buyukatipoglu; Zekeriya Kucukdurmaz; Ramazan Geyik
Journal:  Clin Rheumatol       Date:  2009-10-16       Impact factor: 2.980

2.  [Acute and chronic anal ulcers].

Authors:  G H Weyandt
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

3.  Analysis of 27 cases of large vascular lesions in 161 cases of Behcet's disease: clinical manifestations and treatment outcome.

Authors:  Shengguang Li
Journal:  Clin Rheumatol       Date:  2014-01-15       Impact factor: 2.980

4.  Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.

Authors:  Fuat Duygulu; Cem Evereklioglu; Mustafa Calis; Murat Borlu; Mustafa Cekmen; Ozcan Ascioglu
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

5.  Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.

Authors:  Gul Sagun; Aytekin Oguz; Banu Mesci; Banu Isbilen; Mukaddes Kavala; Havva Keskin; Mumtaz Takir; Sibel Zehra Aydin
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

6.  The association between total antioxidant status and oxidative stress in Behçet's disease.

Authors:  Aylin Sepici-Dinçel; Yeşim Ozkan; Sevgi Yardim-Akaydin; Gülçin Kaymak-Karataş; Meltem Onder; Bolkan Simşek
Journal:  Rheumatol Int       Date:  2006-05-20       Impact factor: 2.631

Review 7.  Cardiac manifestations in Behcet's disease.

Authors:  Selami Demirelli; Husnu Degirmenci; Sinan Inci; Arif Arisoy
Journal:  Intractable Rare Dis Res       Date:  2015-05

8.  Neurotological status in Behçet's disease and its ophthalmological correlates.

Authors:  Y A Bayazit; C Evereklioğlu; E Ozer; N Kirtak; N Bayazit; M Kanlikama; S Inalöz
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

9.  Expression of Th-17 and RORγt mRNA in Behçet's Disease.

Authors:  Kamel Hamzaoui; Eya Bouali; Imed Ghorbel; Monia Khanfir; Habib Houman; Agnes Hamzaoui
Journal:  Med Sci Monit       Date:  2011-04

10.  Restless Legs Syndrome in Patients with Behçet's Disease and Multiple Sclerosis: Prevalence, Associated Conditions and Clinical Features.

Authors:  Ayşenur Önalan; Zeliha Matur; Münevver Pehlıvan; Gülşen Akman
Journal:  Noro Psikiyatr Ars       Date:  2018-07-09       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.